UEEC (United Health Products) Beneish M-Score : 0.00 (As of Dec. 13, 2024)

View and export this data going back to . Start your Free Trial

What is United Health Products Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for United Health Products's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of United Health Products was -8.85. The lowest was -161.65. And the median was -31.64.

United Health Products Beneish M-Score Historical Data

The historical data trend for United Health Products's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Health Products Beneish M-Score Chart

United Health Products Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beneish M-Score

Get a 7-Day Free Trial

United Health Products Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Beneish M-Score	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of United Health Products's Beneish M-Score

For the Medical Instruments & Supplies subindustry, United Health Products's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

United Health Products's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, United Health Products's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where United Health Products's Beneish M-Score falls into.

United Health Products Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of United Health Products for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 *

0.528 *

0.404 *

0.892 *

0.115 *

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 *

4.679 *

0.327 *

This Year (Sep24) TTM:

Last Year (Sep23) TTM:

Total Receivables was $0.00 Mil.
Revenue was 0 + 0 + 0 + 0 = $0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = $0.00 Mil.
Total Current Assets was $0.06 Mil.
Total Assets was $0.15 Mil.
Property, Plant and Equipment(Net PPE) was $0.06 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.00 Mil.
Selling, General, & Admin. Expense(SGA) was $1.27 Mil.
Total Current Liabilities was $2.24 Mil.
Long-Term Debt & Capital Lease Obligation was $0.03 Mil.
Net Income was -0.304 + -0.432 + -0.452 + -0.472 = $-1.66 Mil.
Non Operating Income was 0.115 + 0 + 0 + 0 = $0.12 Mil.
Cash Flow from Operations was -0.32 + -0.288 + -0.406 + -0.577 = $-1.59 Mil.

Total Receivables was $0.00 Mil.
Revenue was 0 + 0 + 0 + 0 = $0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = $0.00 Mil.
Total Current Assets was $0.14 Mil.
Total Assets was $0.34 Mil.
Property, Plant and Equipment(Net PPE) was $0.08 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.00 Mil.
Selling, General, & Admin. Expense(SGA) was $1.88 Mil.
Total Current Liabilities was $2.06 Mil.
Long-Term Debt & Capital Lease Obligation was $0.06 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(0 / 0)	/	(0 / 0)
	=		/
	=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(0 / 0)	/	(0 / 0)
	=		/
	=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (0.064 + 0.055) / 0.151)	/	(1 - (0.138 + 0.083) / 0.336)
	=	0.211921	/	0.342262
	=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	0	/	0
	=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(0.004 / (0.004 + 0.083))	/	(0.004 / (0.004 + 0.055))
	=	0.045977	/	0.067797
	=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(1.268 / 0)	/	(1.878 / 0)
	=		/
	=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((0.026 + 2.235) / 0.151)	/	((0.055 + 2.063) / 0.336)
	=	14.97351	/	6.303571
	=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(-1.66 - 0.115	-	-1.591)	/	0.151
	=	-1.218543

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

United Health Products Beneish M-Score Related Terms

Thank you for viewing the detailed overview of United Health Products's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

United Health Products Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » United Health Products Inc (OTCPK:UEEC) » Definitions » Beneish M-Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

520 Fellowship Road, Suite No D-406, Mt. Laurel, NJ, USA, 08054

Website

https://www.uhpcorp.com

United Health Products Inc is a United States-based company. It mainly manufactures and markets a patented hemostatic gauze for the healthcare and wound care sectors. The company's product HemoStyp is derived from regenerated oxidized cellulose, which is naturally designed to absorb exudate from superficial wounds and helps control bleeding. It markets its product to dental and medical markets as well as, sports, military and veterinary sectors, and others. The company's trademarks include Boo Boo Strips; The Ultimate Bandage; Hemostrips; CelluSTAT and Nik Fix.

Executives

Brian David Thom	officer: CEO	10624 S EASTERN AVE., STE A209, HENDERSON NV 89052
Kristofer Heaton	officer: Vice-President Finance, CFO	526 COMMERCE CIRCLE, STE 120, MESQUITE NV 89027
Nate Knight	director	C/O MORSE & MORSE, PLLC, 1400 OLD COUNTRY ROAD, SUITE 302, WESTBURY NY 11590
Louis Schiliro	officer: Chief Operating Officer	10624 S. EASTERN AVENUE, STE. A209, HENDERSON NV 89052
Douglas K Beplate	officer: CEO
Robert J. Denser	director	10624 S. EASTERN AVE., STE. A209, HENDERSON NV 89052
John Vito Capotorto	director	1090 KING GEORGES POST ROAD, SUITE 501, EDISON NJ 08837
Sherman Lazrus	director
Rodney Paul Leibowitz	director	420 EAST 54TH STREET, APARTMENT 15B, NEW YORK NY 10022
Michael R. Wiechnik	director	11 PRESWICK DR., MEDFORD NJ 08055
Richard Rifenburgh	director	2637 E. ATLANTIC BLVD., #133, POMPANO BEACH FL 33062
Phillip David Forman	director, officer: President, Chairman and CEO	1090 KING GEORGES POST RD,501, EDISON NJ 08837
Jan E Chason	director, officer: Chief Financial Officer	120 WALL STREET, SUITE 2401, NEW YORK NY 10005
Kelly Thomas Hickel	director, officer: Chief Executive Officer	1630A 30TH STREET, SUITE 300, BOULDER CO 80301
Patrick Donelan	10 percent owner	3570 LAKEVIEW DRIVE, DELRAY BEACH FL 33445